MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Tagged Melbourne Brain Centre

Melbourne Brain Centre Symposium & MStranslate

MStranslate
December 1, 2014
Social Media, Symposium
Last Friday, MStranslate attended the 4th annual Melbourne Brain Centre (MBC) symposium, held at the University of Melbourne.  Focussed on the topic...

An Explanation of Magnetic Resonance Imaging (MRI)

MStranslate
May 1, 2014
Neuroimaging
As magnetic resonance imaging (MRI) plays a key role in the diagnosis of multiple sclerosis, we took the opportunity to ask Professor Roger Ordidge,...

A New Technique to Assess Outcomes of Optic Neuritis

MStranslate
April 30, 2014
Neuroimaging
Optic neuritis (inflammation of the optic nerve, (ON)) causes visual loss and is a common early symptom of multiple sclerosis (MS). Patients with ON...

Understanding the Different Outcomes of Optic Neuritis

MStranslate
April 29, 2014
Neuroimaging, Research
Optic neuritis (inflammation of the optic nerve) is a common side-effect of multiple sclerosis (MS) and leads to many sight-related difficulties,...

Fingolimod After Natalizumab & Short-term Relapse Risk

MStranslate
March 27, 2014
Fingolimod, Natalizumab, Research, Treatments
Dr Vilija Jokubaitis et al Natalizumab (Tysabri) is an antibody used for the treatment of multiple sclerosis (MS). It is currently the strongest...

An Introduction to MSBase by A/Prof Helmut Butzkueven

MStranslate
March 25, 2014
Research
MSBase is an international multiple sclerosis (MS) registry that is helping answer many questions about MS. In this short video, Associate...

Sex as a Determinant of Relapse Incidence & MS Progression

MStranslate
March 20, 2014
Research
Dr Tomas Kalincik et al Relapses of MS activity present with worsening of neurological symptoms and are usually followed by periods of stability....
collaboration

MStranslate and Melbourne Brain Centre Announce Collaboration

MStranslate
February 20, 2014
Collaboration
MStranslate is excited to announce a new collaboration with the Melbourne Brain Centre at Royal Melbourne Hospital (MBC@RMH).  This opportunity...
Melbourne Brain Centre

2013 Melbourne Brain Centre Symposium Presentation

MStranslate
October 21, 2013
Presentations
For those who are interested, here is the presentation we delivered at the Melbourne Brain Centre Symposium in November 2013. It outlines the role of...
symposium

Melbourne Brain Centre Symposium 2013 Dinner

MStranslate
October 17, 2013
Events, Symposium
Our invitation to present at the 2013 Melbourne Brain Centre Symposium included attending the event dinner on the night before the event. Held at...
  1. 1
  2. 2

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.